ESPR Total Non-Current Liabilities
Esperion Therapeutics Inc · Total Non-Current Liabilities
ESPR Total Non-Current Liabilities
Latest reported$470.10Mperiod ending
ESPR Quarterly Total Non-Current Liabilities ($2.12M → $470.10M)
Quarterly total non-current liabilities
High-resolution chart · PNG
ESPR total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 470,101,000 | |
| 467,041,000 | |
| 456,348,000 | |
| 481,798,000 | |
| 479,274,000 | |
| 486,310,000 | |
| 518,450,000 | |
| 521,201,000 | |
| 502,846,000 | |
| 504,566,000 | |
| 493,601,000 | |
| 499,431,000 | |
| 485,996,000 | |
| 479,409,000 | |
| 524,582,000 | |
| 513,403,000 | |
| 512,808,000 | |
| 505,182,000 | |
| 509,476,000 | |
| 502,127,000 | |
| 450,107,000 | |
| 355,323,000 | |
| 166,061,999 | |
| 160,982,000 | |
| 156,435,000 | |
| 128,417,000 | |
| 129,240,000 | |
| 125,168,000 | |
| 1,447,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 140,000 | |
| 585,000 | |
| 1,022,000 | |
| 1,451,000 | |
| 1,871,000 | |
| 2,283,000 | |
| 2,688,000 | |
| 3,084,000 | |
| 3,473,000 | |
| 3,855,000 | |
| 4,299,000 | |
| 4,676,000 | |
| 4,922,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,528,845 | |
| 8,074,000 | |
| 7,948,000 | |
| 7,721,000 | |
| 7,731,000 | |
| 7,221,000 | |
| 7,437,000 | |
| 6,921,000 | |
| 5,482,000 | |
| 5,386,000 | |
| 5,129,000 | |
| 3,307,000 | |
| 3,027,000 | |
| 2,483,000 | |
| 1,975,000 | |
| 2,123,469 |